187 related articles for article (PubMed ID: 22233400)
41. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
42. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
[TBL] [Abstract][Full Text] [Related]
43. CD30+ large cell transformation of mycosis fungoides after psoralen plus ultraviolet A photochemotherapy.
Ogino J; Saga K; Kagaya M; Kamada A; Hirosaki K; Kaneko R; Jimbow K
Br J Dermatol; 2007 Jan; 156(1):148-51. PubMed ID: 17199582
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
Niwamoto T; Handa T; Murase Y; Nakatsuka Y; Tanizawa K; Taguchi Y; Tomioka H; Tomii K; Kita H; Uyama M; Tsuchiya M; Emura M; Kawamura T; Arai N; Arita M; Uno K; Yoshizawa A; Uozumi R; Yamaguchi I; Matsuda F; Chin K; Hirai T
Respir Res; 2021 Jun; 22(1):181. PubMed ID: 34158044
[TBL] [Abstract][Full Text] [Related]
45. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
46. Combination of local PUVA-therapy and interferon alpha-2A in the treatment of tumoral stage mycosis fungoides.
Delpuget-Bertin N; Bernard P; Bedane C; Dang PM; Bonnetblanc JM
Dermatology; 1996; 193(1):74-5. PubMed ID: 8864634
[No Abstract] [Full Text] [Related]
47. [Folliculotropic mycosis fungoides].
Baratli J; Balakirski G; Megahed M
Hautarzt; 2014 Dec; 65(12):1011-3. PubMed ID: 25355498
[TBL] [Abstract][Full Text] [Related]
48. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa.
Jumbou O; N'Guyen JM; Tessier MH; Legoux B; Dréno B
Br J Dermatol; 1999 Mar; 140(3):427-31. PubMed ID: 10233261
[TBL] [Abstract][Full Text] [Related]
50. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
51. The treatment of mycosis fungoides.
Mestel DS; Beyer M; Steinhoff M; Sterry W; Assaf C
G Ital Dermatol Venereol; 2008 Dec; 143(6):395-408. PubMed ID: 19169212
[TBL] [Abstract][Full Text] [Related]
52. Treatment of localized mycosis fungoides with digital UV photochemotherapy.
Reidel U; Bechstein S; Lange-Asschenfeldt B; Beyer M; Vandersee S
Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):333-40. PubMed ID: 26284356
[TBL] [Abstract][Full Text] [Related]
53. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
54. A rare presentation of erythrodermic mycosis fungoides.
Goyal T; Varshney A
Cutis; 2012 May; 89(5):229-32, 236. PubMed ID: 22768436
[TBL] [Abstract][Full Text] [Related]
55. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
[TBL] [Abstract][Full Text] [Related]
56. Hyperpigmentation as a peculiar presentation of mycosis fungoides.
Lu YY; Wu CH; Lu CC; Hong CH
An Bras Dermatol; 2017; 92(5 Suppl 1):92-94. PubMed ID: 29267458
[TBL] [Abstract][Full Text] [Related]
57. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
58. High CCL27 immunoreactivity in 'supratumoral' epidermis correlates with better prognosis in patients with cutaneous malignant melanoma.
Martinez-Rodriguez M; Thompson AK; Monteagudo C
J Clin Pathol; 2017 Jan; 70(1):15-19. PubMed ID: 27325798
[TBL] [Abstract][Full Text] [Related]
59. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group.
Hurabielle C; Ingen-Housz-Oro S; Ortonne N; Cornillet-Lefèbvre P; Merah A; D'Incan M; Joly P; Franck N; Estève E; Maubec E; Grange F; Machet L; Laroche L; Barete S; Dalac S; Mortier L; Michel C; Quereux G; Saiag P; Ram-Wolff C; Lenormand B; Wechsler J; Bastuji-Garin S; Bagot M; Delfau-Larue MH
Br J Dermatol; 2015 Oct; 173(4):1015-23. PubMed ID: 26149621
[TBL] [Abstract][Full Text] [Related]
60. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
Coors E
Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
